fda warning peptides bpc-157 not approved human use for bpc 157 This is the first vote from the FDA's bpc-157 not approved for human – FDA panel votes to place

Available from: National Institutes of Health, Office of Dietary Supplements

Addressing Inflammation in Chronic Diseases: A Functional Medicine Perspective

Taking too much can cause side effects like nausea, headache, dizziness, and, in some cases allergic reactions

This randomized controlled trial demonstrates that myo-inositol supplementation significantly improved weight, insulin resistance, liver function, and metabolic markers in patients with liver disease

Hydroxocobalamin, the form of B12 most commonly used in UK clinical practice, may cause a harmless pink or red discolouration of urine

Disclose any existing medical conditions or medications to avoid interactions